P-gp Inhibitors: Revision history

15 June 2017

• curprev 10:0610:06, 15 June 2017‎ Kirilas talk contribs‎ 8,255 bytes −13‎ No edit summary

15 February 2013

• curprev 09:3709:37, 15 February 2013‎ Kirilas talk contribs‎ 8,268 bytes −11‎ →‎Reference database
• curprev 09:3409:34, 15 February 2013‎ Kirilas talk contribs‎ 8,279 bytes +1‎ →‎Model features & prediction accuracy
• curprev 09:3309:33, 15 February 2013‎ Kirilas talk contribs‎ 8,278 bytes +8‎ →‎Model features & prediction accuracy
• curprev 09:3309:33, 15 February 2013‎ Kirilas talk contribs‎ 8,270 bytes +552‎ →‎Model features & prediction accuracy

29 May 2012

• curprev 13:2513:25, 29 May 2012‎ Kristina talk contribs‎ 7,718 bytes −74‎ →‎Features

25 May 2012

• curprev 09:0109:01, 25 May 2012‎ Kirilas talk contribs‎ 7,792 bytes −53‎ →‎Features
• curprev 08:5908:59, 25 May 2012‎ Kirilas talk contribs‎ 7,845 bytes +219‎ →‎Interface
• curprev 08:5708:57, 25 May 2012‎ Kirilas talk contribs‎ 7,626 bytes −328‎ →‎Features
• curprev 08:5608:56, 25 May 2012‎ Kirilas talk contribs‎ 7,954 bytes −197‎ →‎Interface
• curprev 08:5208:52, 25 May 2012‎ Kirilas talk contribs‎ 8,151 bytes +14‎ →‎Interface
• curprev 08:5108:51, 25 May 2012‎ Kirilas talk contribs‎ 8,137 bytes −150‎ →‎Features

22 May 2012

• curprev 08:1908:19, 22 May 2012‎ Kristina talk contribs‎ 8,287 bytes −1,149‎ No edit summary

21 May 2012

• curprev 13:2313:23, 21 May 2012‎ Kristina talk contribs‎ 9,436 bytes +9,436‎ Created page with "==Overview== <br /> P-glycoprotein (P-gp) is a clinically relevant efflux transporter that extrudes compounds from a large variety of cells. Its function has been associated ..."